Zhou, Q., Yen, A., Rymarczyk, G., Asai, H., Trengrove, C., Aziz, N., . . . Bolotina, V. M. (2016). Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease. Nature Portfolio.
Chicago Style (17th ed.) CitationZhou, Qingde, et al. Impairment of PARK14-dependent Ca2+ Signalling Is a Novel Determinant of Parkinson’s Disease. Nature Portfolio, 2016.
MLA (8th ed.) CitationZhou, Qingde, et al. Impairment of PARK14-dependent Ca2+ Signalling Is a Novel Determinant of Parkinson’s Disease. Nature Portfolio, 2016.
Warning: These citations may not always be 100% accurate.